Fountain Therapeutics, Inc. — Form D
Fountain Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-02-19. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-02-19
- Form: D
- Accession: 0001739815-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Investors: 2
- Date of first sale: 2020-02-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-360904
Issuer
- Name: Fountain Therapeutics, Inc.
- CIK: 0001739815
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 681 Gateway Blvd., South San Francisco, CA, 94080
- Phone: 650-856-1971
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| John Dimos | Director | San Francisco, CA |
| John Dimos | Executive Officer | San Francisco, CA |
| Alex Morgan | Director | Austin, TX |
| William Greene | Director | South San Francisco, CA |
| William Greene | Executive Officer | South San Francisco, CA |
| Thomas Rando | Director | South San Francisco, CA |
| Thomas Rando | Executive Officer | South San Francisco, CA |
| Ashish Khanna | Director | South San Francisco, CA |
| Thomas A Rando | Director | Stanford, CA |
| Thomas A Rando | Executive Officer | Stanford, CA |
| Thomas A Rando | Promoter | Stanford, CA |
Other filings by this issuer (3)
More